Immunological considerations in the development of Pseudomonas aeruginosa vaccines.

Human Vaccines & Immunotherapeutics
Sarah M BakerLisa A Morici

Abstract

Pseudomonas aeruginosa is an opportunistic human pathogen capable of causing a wide range of potentially life-threatening infections. With multidrug-resistant P. aeruginosa infections on the rise, the need for a rationally-designed vaccine against this pathogen is critical. A number of vaccine platforms have shown promising results in pre-clinical studies, but no vaccine has successfully advanced to licensure. Growing evidence suggests that an effective P. aeruginosa vaccine may require Th17-type CD4+ T cells to prevent infection. In this review, we summarize recent pre-clinical studies of P. aeruginosa vaccines, specifically focusing on those that induce Th17-type cellular immunity. We also highlight the importance of adjuvant selection and immunization route in vaccine design in order to target vaccine-induced immunity to infected tissues. Advances in cellular immunology and adjuvant biology may ultimately influence better P. aeruginosa vaccine platforms that can protect targeted human populations.

References

Sep 1, 1987·Canadian Journal of Microbiology·D Drake, T C Montie
Jul 16, 1987·The New England Journal of Medicine·C M KraussD C Page
Oct 1, 1970·American Journal of Surgery·J W Alexander, M W Fisher
Dec 5, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A SuzichR Schlegel
Dec 22, 1999·The European Respiratory Journal·C WojnarowskiR Ziesche
Aug 11, 2000·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·C MoserN Høiby
Aug 22, 2001·Journal of Bacteriology·M HentzerM R Parsek
Oct 6, 2001·American Journal of Respiratory Cell and Molecular Biology·P YeJ K Kolls
Dec 24, 2002·American Journal of Respiratory Cell and Molecular Biology·Jay K KollsAlistair J Ramsay
Oct 16, 2004·Immunity·Jay K Kolls, Anders Lindén
Jan 3, 2006·The Journal of Allergy and Clinical Immunology·Dominik HartlSusanne Krauss-Etschmann
Jun 6, 2006·The Journal of Allergy and Clinical Immunology·Victoria Boswell-SmithClive P Page
May 25, 2007·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·A C BrooksJ Elliott
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Janet E StoutUNKNOWN Legionella Study Group
Jun 15, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David J WeberMichael S Niederman
Jul 4, 2007·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·P J DubinJ K Kolls
Feb 5, 2008·Vaccine·Gerd Döring, Gerald B Pier
Aug 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Per C SaetherErik Dissen
Aug 12, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kristen PageMarsha Wills-Karp
Nov 6, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Beata M ZygmuntCarlos A Guzman
Nov 20, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Igor M Belyakov, Jeffrey D Ahlers
Dec 1, 2009·Critical Care Clinics·Raghukumar ThirumalaSanjay Chawla
Feb 25, 2010·Allergology International : Official Journal of the Japanese Society of Allergology·Takehiro HigashiSho Matsushita
Jul 27, 2010·Allergology International : Official Journal of the Japanese Society of Allergology·Sujoy KhanCarrock Sewell
Nov 16, 2010·Cellular Immunology·Xinshou OuyangHuabao Xiong
Jan 6, 2011·FEMS Immunology and Medical Microbiology·Jialin LiuHuanying Wan
Feb 11, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Michela ManniRichard D Granstein
Jul 26, 2011·The Journal of Clinical Investigation·Bonnie B Blomberg, Daniela Frasca
Aug 3, 2011·Frontiers in Microbiology·Jens KlockgetherBurkhard Tümmler
Aug 16, 2011·Microbes and Infection·Elise G LavoieBarbara I Kazmierczak
Sep 20, 2011·The Journal of Clinical Investigation·Kathleen A PageRajita Sinha
Sep 24, 2011·Human Vaccines·Anurag SharmaStefan Worgall
Dec 20, 2011·Immunity·Pawel MuranskiNicholas P Restifo

❮ Previous
Next ❯

Citations

Mar 18, 2021·Glycoconjugate Journal·Laura MorelliFederica Compostella
May 12, 2021·Life Science Alliance·Géraldine MayeuxJean-Luc Lenormand
Aug 17, 2021·International Journal of Peptide Research and Therapeutics·Sidra IrumMahnoor Majid

❮ Previous
Next ❯

Datasets Mentioned

BETA
GM-CSF

Methods Mentioned

BETA
bronchoalveolar
lavage
biopsies
X-ray

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.